Tasly Pharmaceutical Group Co. Ltd.SSE: 600535

(600535)"TASLY PHARMACEUTICAL GROUP CO., LTD."Announcement on Implementation of Dividend Distribution for the First Half of 2026

· Issued by Tasly Pharmaceutical Group Co. Ltd. via Shanghai Stock Exchange

Filed with SSE · Stock code 600535 · · 3 pages · Chinese

Summary by 6ix AI

The company will distribute a cash dividend per share, with specific dates for registration and payment outlined in the announcement. The filing includes details on the implementation methods for the dividend distribution and tax implications for different types of shareholders. Shareholders are advised to consult the company for any inquiries regarding the dividend distribution process.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

On 6ix: 6ix.com/news/600535tasly-pharmaceutical-group-co-ltdannouncement-on-implementation-of-dividend-distribution-for-the-first-half-of-2026

Release

Announcement on Implementation of Dividend Distribution for the First Half of 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Tasly Pharmaceutical Group Co. Ltd. on 6ix

Story so far

Earlier from Tasly Pharmaceutical

Later from Tasly Pharmaceutical

All Tasly Pharmaceutical news releases